Compile Data Set for Download or QSAR
Report error Found 116 Enz. Inhib. hit(s) with all data for entry = 112
TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176294(US9688696, 9)
Affinity DataIC50: 6.46nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176286(US9688696, 1)
Affinity DataIC50: 8.91nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176337(US9688696, 53)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176338(US9688696, 54)
Affinity DataIC50: 13nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176339(US9688696, 55)
Affinity DataIC50: 15nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176340(US9688696, 56)
Affinity DataIC50: 17nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176341(US9688696, 57)
Affinity DataIC50: 23nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176313(US9688696, 28)
Affinity DataIC50: 25nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176293(US9688696, 8)
Affinity DataIC50: 30nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176314(US9688696, 29)
Affinity DataIC50: 31nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176315(US9688696, 30)
Affinity DataIC50: 32nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176316(US9688696, 31)
Affinity DataIC50: 41nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176342(US9688696, 58)
Affinity DataIC50: 47nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176343(US9688696, 59)
Affinity DataIC50: 74nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176350(US9688696, 66)
Affinity DataIC50: 79nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176317(US9688696, 32)
Affinity DataIC50: 83nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176351(US9688696, 67)
Affinity DataIC50: 85nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176344(US9688696, 60)
Affinity DataIC50: 98nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176318(US9688696, 33)
Affinity DataIC50: 105nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176287(US9688696, 2)
Affinity DataIC50: 110nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176312(US9688696, 27)
Affinity DataIC50: 120nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176352(US9688696, 68)
Affinity DataIC50: 129nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176319(US9688696, 34)
Affinity DataIC50: 141nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176320(US9688696, 35)
Affinity DataIC50: 145nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176321(US9688696, 36)
Affinity DataIC50: 151nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176345(US9688696, 61)
Affinity DataIC50: 151nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176353(US9688696, 69)
Affinity DataIC50: 166nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176322(US9688696, 37)
Affinity DataIC50: 174nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176354(US9688696, 70)
Affinity DataIC50: 182nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176323(US9688696, 38)
Affinity DataIC50: 275nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176291(US9688696, 6)
Affinity DataIC50: 302nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176295(US9688696, 10)
Affinity DataIC50: 316nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176346(US9688696, 62)
Affinity DataIC50: 339nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176324(US9688696, 39)
Affinity DataIC50: 398nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176289(US9688696, 4)
Affinity DataIC50: 407nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176325(US9688696, 40)
Affinity DataIC50: 407nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176309(US9688696, 24)
Affinity DataIC50: 447nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176288(US9688696, 3)
Affinity DataIC50: 501nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM181674(US9688696, 41)
Affinity DataIC50: 603nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176290(US9688696, 5)
Affinity DataIC50: 661nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176310(US9688696, 25)
Affinity DataIC50: 741nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176327(US9688696, 42)
Affinity DataIC50: 741nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176328(US9688696, 43)
Affinity DataIC50: 759nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176347(US9688696, 63)
Affinity DataIC50: 759nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176355(US9688696, 71)
Affinity DataIC50: 794nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176356(US9688696, 72)
Affinity DataIC50: 832nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176357(US9688696, 73)
Affinity DataIC50: 912nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176329(US9688696, 44)
Affinity DataIC50: 933nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176330(US9688696, 45)
Affinity DataIC50: 933nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

TargetDiacylglycerol O-acyltransferase 1(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM176358(US9688696, 74)
Affinity DataIC50: 955nMpH: 7.4 T: 2°CAssay Description:DGAT activity in membrane preparations was assayed in 50 mM Tris-HCl (pH 7.4), 150 mM MgCl2, 1 mM EDTA and 0.2% BSA, containing 50 μM DAG, 32 &#...More data for this Ligand-Target Pair
In Depth
Date in BDB:
4/12/2018
Entry Details
Go to US Patent

Displayed 1 to 50 (of 116 total ) | Next | Last >>
Jump to: